Spot-On Skin Lipid Complex as an Adjunct Therapy in Dogs with Atopic Dermatitis: An Open Pilot Study
Figure 1
(a) CADESI-03 modification total score improved 6 weeks (D0 + 6W) and 12 weeks (D0 + 12W) after starting treatment (D0) with topical SLC. Results are expressed as mean, . *, compared with D0 score. Number below the abscissa axis indicates average difference rate (%) from D0. (b) Erythema improved dramatically during the trial period. Results are expressed as mean, . *, ***, compared with D0 score. Number below the abscissa axis indicates average difference rate (%) from D0. (c) Mean lichenification subscore. Results are expressed as mean, . Number below the abscissa axis indicates average difference rate (%) from D0. (d) Excoriation improved during the trial period. Results are expressed as mean, . *, compared with D0 score. Number below the abscissa axis indicates average difference rate (%) from D0. (e) Alopecia improved during the trial period. Results are expressed as mean, . *, compared with D0 score. Number below the abscissa axis indicates average difference rate (%) from D0.
